P-glycoprotein deficient mouse in situ blood–brain barrier permeability and its prediction using an in combo PAMPA model
Authors:
- 1 September 2009
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 38 (2) , 121-137
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Comparison of blood–brain barrier permeability assays: in situ brain perfusion, MDR1-MDCKII and PAMPA-BBBJournal of Pharmaceutical Sciences, 2009
- In silico prediction of brain and CSF permeation of small molecules using PLS regression modelsEuropean Journal of Medicinal Chemistry, 2008
- New Predictive Models for Blood–Brain Barrier Permeability of Drug-like MoleculesPharmaceutical Research, 2008
- On The Rate and Extent of Drug Delivery to the BrainPharmaceutical Research, 2007
- High-Throughput Screening of Drug−Brain Tissue Binding and in Silico Prediction for Assessment of Central Nervous System Drug DeliveryJournal of Medicinal Chemistry, 2007
- In Silico Prediction of Blood Brain Barrier Permeability: An Artificial Neural Network ModelJournal of Chemical Information and Modeling, 2005
- Prediction of blood–brain barrier penetration: are we missing the point?Drug Discovery Today, 2004
- Development of an In Situ Mouse Brain Perfusion Model and its Application to mdr1a P-Glycoprotein-Deficient MiceJournal of Cerebral Blood Flow & Metabolism, 2000
- Microdialysis—Theory and applicationProgress in Neurobiology, 1990
- Phenylalanine Transport Across the Blood‐Brain Barrier as Studied with the In Situ Brain Perfusion TechniqueJournal of Neurochemistry, 1987